Vikram Bhattacharjee

484 total citations
10 papers, 305 citations indexed

About

Vikram Bhattacharjee is a scholar working on Molecular Biology, Oncology and Plant Science. According to data from OpenAlex, Vikram Bhattacharjee has authored 10 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Plant Science. Recurrent topics in Vikram Bhattacharjee's work include Pancreatic and Hepatic Oncology Research (3 papers), DNA Repair Mechanisms (3 papers) and CRISPR and Genetic Engineering (2 papers). Vikram Bhattacharjee is often cited by papers focused on Pancreatic and Hepatic Oncology Research (3 papers), DNA Repair Mechanisms (3 papers) and CRISPR and Genetic Engineering (2 papers). Vikram Bhattacharjee collaborates with scholars based in United States. Vikram Bhattacharjee's co-authors include Tim J. Yen, Andrew J. Andrews, Christopher D. Marion, Yin‐Ming Kuo, Ryan A. Henry, Alan S. Waldman, Barbara Criscuolo Waldman, Neil Beeharry, Jason P. Smith and Masaya Jimbo and has published in prestigious journals such as PLoS ONE, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Vikram Bhattacharjee

10 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vikram Bhattacharjee United States 7 242 100 90 32 28 10 305
Fuqin Su China 11 249 1.0× 86 0.9× 104 1.2× 30 0.9× 29 1.0× 13 351
Yunqiao Li China 7 190 0.8× 76 0.8× 69 0.8× 9 0.3× 24 0.9× 10 300
Shakur Mohibi United States 11 347 1.4× 125 1.3× 78 0.9× 16 0.5× 10 0.4× 21 413
Ryan Janke United States 7 210 0.9× 70 0.7× 80 0.9× 18 0.6× 55 2.0× 7 322
Marc A. Vittoria United States 7 208 0.9× 69 0.7× 74 0.8× 30 0.9× 12 0.4× 10 324
Manuel D. Haschka Austria 8 304 1.3× 34 0.3× 123 1.4× 21 0.7× 14 0.5× 10 397
M. Virginia C. L. Appleyard United Kingdom 9 251 1.0× 101 1.0× 148 1.6× 41 1.3× 6 0.2× 10 346
Gourish Mondal United States 11 304 1.3× 79 0.8× 110 1.2× 25 0.8× 42 1.5× 15 459
Nurmaa K. Dashzeveg Japan 10 243 1.0× 141 1.4× 130 1.4× 7 0.2× 18 0.6× 12 368
E Turpin France 10 197 0.8× 94 0.9× 144 1.6× 11 0.3× 13 0.5× 20 353

Countries citing papers authored by Vikram Bhattacharjee

Since Specialization
Citations

This map shows the geographic impact of Vikram Bhattacharjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikram Bhattacharjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikram Bhattacharjee more than expected).

Fields of papers citing papers by Vikram Bhattacharjee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikram Bhattacharjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikram Bhattacharjee. The network helps show where Vikram Bhattacharjee may publish in the future.

Co-authorship network of co-authors of Vikram Bhattacharjee

This figure shows the co-authorship network connecting the top 25 collaborators of Vikram Bhattacharjee. A scholar is included among the top collaborators of Vikram Bhattacharjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vikram Bhattacharjee. Vikram Bhattacharjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kim, Dae‐Hwan, et al.. (2018). Methotrexate sensitizes drug-resistant metastatic melanoma cells to BRAF V600E inhibitors dabrafenib and encorafenib. Oncotarget. 9(17). 13324–13336. 9 indexed citations
2.
3.
Ursu, Oana, Sara J.C. Gosline, Neil Beeharry, et al.. (2017). Network modeling of kinase inhibitor polypharmacology reveals pathways targeted in chemical screens. PLoS ONE. 12(10). e0185650–e0185650. 2 indexed citations
4.
Lal, Shruti, Richard A. Burkhart, Neil Beeharry, et al.. (2014). HuR Posttranscriptionally Regulates WEE1: Implications for the DNA Damage Response in Pancreatic Cancer Cells. Cancer Research. 74(4). 1128–1140. 83 indexed citations
5.
Bhattacharjee, Vikram, et al.. (2014). A synthetic lethal screen identifies the Vitamin D receptor as a novel gemcitabine sensitizer in pancreatic cancer cells. Cell Cycle. 13(24). 3839–3856. 24 indexed citations
6.
Henry, Ryan A., Yin‐Ming Kuo, Vikram Bhattacharjee, Tim J. Yen, & Andrew J. Andrews. (2014). Changing the Selectivity of p300 by Acetyl-CoA Modulation of Histone Acetylation. ACS Chemical Biology. 10(1). 146–156. 59 indexed citations
7.
Bhattacharjee, Vikram, Yunfu Lin, Barbara Criscuolo Waldman, & Alan S. Waldman. (2013). Induction of recombination between diverged sequences in a mammalian genome by a double-strand break. Cellular and Molecular Life Sciences. 71(12). 2359–2371. 4 indexed citations
8.
Bhattacharjee, Vikram. (2010). Abstract 657: Identification and characterization of genes that sensitize pancreatic cancer cells to gemcitabine. Cancer Research. 70(8_Supplement). 657–657. 1 indexed citations
9.
Smith, Jason P., Laura Bannister, Vikram Bhattacharjee, et al.. (2007). Accurate Homologous Recombination Is a Prominent Double-Strand Break Repair Pathway in Mammalian Chromosomes and Is Modulated by Mismatch Repair Protein Msh2. Molecular and Cellular Biology. 27(22). 7816–7827. 33 indexed citations
10.
Ganko, Eric, et al.. (2006). LTR Retrotransposon-Gene Associations in Drosophila melanogaster. Journal of Molecular Evolution. 62(1). 111–120. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026